Sandoz
Business
Swiss Generic Drugmaker Sandoz Lowered its Full-Year Sales Growth
Sandoz shares fell over 5% after the drugmaker lowered its 2026 sales growth forecast, despite raising its core earnings margin outlook.
Business
Sandoz shares fell over 5% after the drugmaker lowered its 2026 sales growth forecast, despite raising its core earnings margin outlook.